2. • Commonly encountered in Practice
• Diagnosis often is made incidentally
• The most common causes are primary
hyperparathyroidism and malignancy
• Diagnostic work-up includes measurement
of serum calcium, intact parathyroid
hormone (I-PTH), h/o any medications
• Hypercalcemic crisis is a life-threatening
emergency
2
3. • Most often asymptomatic – Incidental Dx
• Mild Hypercalcemia is asymptomatic
• Most important cause is hyper parathyroid
• DD is needed to decide the treatment
• Optimal step by step evaluation is a must.
3
4. • 98% of the body calcium is in the skeleton
• Only 2% is circulation and only half of this
is free calcium (ionized Ca++)
• This only is physiologically active
• The reminder 1% is bound to proteins
• Direct measurement of free Calcium ??
4
8. Hormone Effect Bone Gut Kidney
PTH Ca Po4
Increases
Osteoclasts
Indirect
via Vit. D
Ca reab
Po4 exr.
Vitamin D3 Ca Po4
No direct
action
Ca Po4
absorption
No direct
effect
Calcitonin Ca Po4
Inhibits
Osteoclasts
No direct
effect
Ca & Po4
excretion
8
9. Corrected total calcium (mg%) =
[(Measured total calcium mg%) +
{(4.4 - measured albumin g%) x 0.8}]
Example:
[12.0 + {(4.4 – 2.4) x 0.8}] =
[ 12.0 + (2 x 0.8)] = 12.0 + 1.6 = 13.6
mg%
9
11. Second hydroxylation in the Kidney at first position
1,25 dihydroxy Cholecalciferol Active Vitamin D (Calcitriol)
Successive hydroxylations of Cholecalciferol
25 hydroxylation in the Liver 25 hydroxy Cholecalciferol
Vitamin D is a steroid hormone
From dietary sources Action of Sunlight on skin
11
12. PTH
• 4 PT glands
• 84 AA
hormone
• Low Ca
stimulates it
Calcitriol (D)
• Active bone
formation
• Main effect is
on the Gut
• PTH Vit. D
Calcitonin
• Para follicular
C of Thyroid
• 34 AA hormone
• On Kidney
12
13. 13
Critical - > 14 mg %
Moderate - 12 to 14 mg %
Mild – 10.4 to 11.9 mg %
Normal – 8.5 to 10.3 mg %
16. • More than 90 percent of hypercalcemia cases are
Primary hyperparathyroidism and malignancy
• These conditions must be differentiated early
to provide optimal treatment & accurate prognosis
• Humoral hypercalcemia of malignancy implies a
very limited life expectancy — only a matter of
weeks
• Primary hyperparathyroidism has a benign course.
16
17. • Primary hyperparathyroidism
• Sporadic, familial, associated with
Multiple Endocrine Neoplasia (MEN I or II)
• Tertiary hyperparathyroidism
• Associated with chronic renal failure
• PTH due to Vitamin D deficiency
17
18. • Vitamin D intoxication
• Iatrogenic Vitamin D injections
• Usually 25-hydroxyvitamin D2 in
over-the-counter supplements
• Granulomatous disease –
Sarcoidosis, Berylliosis, Tuberculosis
• Hodgkin’s lymphoma
18
19. • Humoral hypercalcemia of malignancy
(mediated by PTHrP) – common cause
• Solid tumors, especially lung, head and
neck squamous cancers
• Renal Cell Carcinoma (RCC)
• Local osteolysis (mediated by cytokines)
• Multiple Myeloma
• Breast cancer
19
20. • Thiazide diuretics (usually mild) - common
• Lithium for depressive illnesses
• Milk-alkali syndrome (calcium + antacids)
• Vitamin A intoxication (including
analogs used to treat acne)
20
33. 33
• Increased screening for serum Ca++ and
• Wider availability of I-PTH assay
• 80% of cases single parathyroid adenoma
• Usually benign adenoma or hyperplasia
• Rarely parathyroid cancer
• High PTH in the setting of hypercalcemia
• Slowly progressive – Sestamibi N-scan
• 25% require surgery – RLN paralysis
34. 34
64 yrs male - “hyper parathyroid storm”
with a serum calcium level of 16.4 mg%
35. • Serum calcium level > 12 mg % at any time
• Episodes of hyper parathyroid crisis
• Marked hypercalciuria (urinary Ca++ > 400 mg /day)
• Nephrolithiasis; Impaired renal function
• Osteitis fibrosa cystica – Thinning of cortical bone
• Reduced bone density by DEXA scan (Z score < 2)
• Classic neuromuscular symptoms, Proximal muscle
weakness and atrophy, Hyper reflexia and ataxia
• Age younger than 50 years
35
36. 36
• 25 OH - Vitamin D2 is the supplemental Vit D
• Level of 25 OH – Vitamin D3 is to be measured
• Macrophages in the granulomas, lymphomas
cause extra renal conversion of 25 OH form to
the1,25 hydroxy derivative –the active Calcitriol
• PTH levels are suppressed; Calcitriol levels
• Stop the offending use of Vitamin D
• Glucocorticoids – for over one month or more
• Manage hypercalcemia vigorously
37. 37
• Most commonly mediated by systemic PTHrP
• Humoral Hypercalcemia of malignancy
• PTHrP mimics the bone & renal effects of PTH
• Normal Calcitriol and suppressed PTH levels
• Excessive bone lysis due to primary or bone
secondaries can cause hypercalcemia
• MM and metastatic Br Ca present in this way.
• In Osteolytic hypercalcemia, SAP is markedly
• Hodgkin’s lymphoma – production of Calcitriol
38. • Thiazide diuretics increase renal calcium
resorption and cause mild hypercalcemia
• Resolves after discontinuing the drug
• Thiazide unmasks hyperparathyroidism
• Milk–alkali syndrome – Ca + Antacids
• Lithium – the set point for PTH
• Excess Vitamin A - bone resorption and
causes hypercalcemia.
38
39. • FHH – Familial Hypocalciuric Hypercalcemia
• AD – 100% penetrance – Ca-R gene mutation
• Moderate hypercalcemia with normal/ PTH
• 24 hour urinary calcium is very low
• No benefit from parathyroidectomy
• High bone turnover in Paget’s disease or
prolonged immobilization
• Recovery phase of Rhabdomyolysis
39
40. • Ca <12 but > 10.3 mg% – no appreciable
clinical benefit – they need evaluation
• Any patient with Serum Ca > 12 mg%
should be aggressively treated
• Ca > 14 mg% is Hypercalcemic crisis
• Always correct the Ca value for Sr
Albumin
40
42. • Vigorous I.V. Nacl Diuresis – N Saline
• Adequate hydration – urine out put must be
maintained 200 ml/hour = 5 L /day
• The safest and most effective treatment of
Hypercalcemic crisis is saline rehydration
• Once the urine out put is maintained – give I.V.
Furosemide – a loop diuretic in low doses of 10
to 20 mg
• ERT - might be beneficial in PMW – new RCT
42
43. • In severe hypercalcemia refractory to
saline diuresis
• Calcitonin (Zycalcit, Miacalcin) 6 -8 U/kg
IM/SC (400 i.u) given every six hours.
• This treatment has a rapid onset but short
duration of effect
• Patients develop tolerance to the calcium-
lowering effect of Calcitonin.
43
44. • Zoledronic acid (Zometa) - 4 mg IV diluted in
100 ml of N Saline - over at least 15’ once a
M
• Pamindronate (Pamidria) - 60 mg IV infusion
over 4 h initial – repeated after a month
• Etidronate (Didronel) - 7.5 mg/kg IV over 4 h
daily for 3-7 d; dilute in at least 250 ml of
sterile N Saline
• They inhibit bone resorption, inhibit the
Osteoclastic activity. 44
45. • Dialysis for refractory Hypercalcemic crisis
• Parathyroidectomy for adenomas
• Rx. of the underlying cause – Eliminate drugs
• Plicamycin (Mithracin) 25 mcg/kg/d IV for 4 d
• Gallium nitrate (Ganite) 100 mg/m2/d IV for 5
days in 1 L of NS or 5% Dextrose
• Cinacalcet (Sensipar) - 30 mg PO od –
(increases sensitivity of calcium sensing
receptor) 45
46. • Hypercalcemia is often asymptomatic
• Screen all suspected by doing Sr Calcium
• If elevated, do I-PTH and follow algorithm
• 90% Hyperparathyroidism and malignancy
• Vitamin D toxicity is an important cause
• Thiazide diuretics common cause, Vitamin A
• Adequate hydration - N Saline + Furosemide
• Calcitonin + Zoledronic acid main stay of Rx.
46